Skip to main content

Table 1 Summary of baseline characteristics and demographic data

From: Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study

Age (yrs) Height (cm) Weight (kg) Sex (F/M) PEFR (L/min) FEV1(% predicted)
Mean (SD) Mean (SD) Mean (SD) N (%) Mean (SD) Mean % (SD)
Children with asthma (age 6–11; n = 23)
8.57 (2.00) 134.26 (18.25) 37.08 (13.64) F 9 (39.13) 182.74 (88.01) Not applicable
M 14 (60.87)
Adolescents with asthma (age 12–17; n = 27)
14.52 (1.55) 160.54 (7.63) 57.73 (12.17) F 14 (51.85) 310.07 (104.36) 64.63 (15.89)
M 13 (48.15)
Adults with asthma (age 18–45; n = 50)
34.74 (7.69) 168.06 (4.92) 75.48 (10.49) F 29 (58.00) 329.48 (101.51) 69.28 (16.63)
M 21 (42.00)
Adults with COPD (age > 50; n = 50)
66.82 (7.98) 168.74 (6.94) 78.09 (13.62) F 28 (56.00) 216.48 (93.25) 51.88 (21.90)
M 22 (44.00)
Healthy volunteers (age 18–45; n = 50)
32.62 (7.34) 171.20 (7.86) 73.82 (14.07) F 29 (58.00) 479.30 (127.58) 95.76 (14.31)
M 21 (42.00)